spacer gif spacer gif spacer gif spacer gif spacer gif
 QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    


Right arrow Help viewing high resolution images
Right arrow Return to article
(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)

Click on image to view larger version.


Figure 8


Fig. 8. Enhanced survival of Inv-Dsg2 keratinocytes in forced suspension culture is dependent on NF-{kappa}B activation. (A) Clonal growth of control and Inv-Dsg2 cell lines after 0, 24, 48 and 72 hours in forced suspension culture was assessed by replating cells on tissue culture plastic and allowing cell proliferation for 7-9 days after replating. Inv-Dsg2 transgenic cells showed dramatically increased survival and re-growth compared to wild-type cells, in this setting. (B) Inv-Dsg2 transgenic cells were subjected to cell suspension culture for 48 hours with EGF and/or Bay11-7082, an I{kappa}B-alpha phosphorylation inhibitor. Cell survival was assessed by replating cells on tissue cultured-treated plastic for 7 days. Activation of the EGF receptor with exogenous EGF further enhanced survival of Inv-Dsg2 transgenic cells in forced suspension cultures. Bay11-7082 inhibition of NF-{kappa}B completely abolished cell survival in suspension culture. EGF-R activation was unable to counteract the effect of Bay11-7082. (C) Immunoblot analysis of NF-{kappa}B p65 expression in wild-type and transgenic skin. Actin was used as a loading control. (D) Immunoblot results were confirmed by immunofluorescent staining, which showed the presence of NF-{kappa}B p65 in nuclei of transgenic but not wild-type skin. Dotted lines demarcate dermal-epidermal junction. Bars, 50 µm.





Right arrow Return to article